China First Domestic COVID-19 Antibody Therapy Moves Towards Green Light

Strong Overseas Efficacy Data

 
• By Brian Yang
  
CHINA PUBLIC HEALTH FIGURE ZHONG NANSHAN (FOURTH FORM LEFT) LEADS BRII PHASE II STUDY IN CHINA • Source: Scrip

More from China

More from Focus On Asia